Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
IRTC Stock Chart & Stats
$182.67
-$0.21(-0.23%)
At close: 4:00 PM EST
$182.67
-$0.21(-0.23%)
Day’s Range― - ―
52-Week Range$67.92 - $188.53
Previous CloseN/A
Volume94.23K
Average Volume (3M)336.40K
Market Cap
$5.95B
Enterprise Value$5.11B
Total Cash (Recent Filing)$545.54M
Total Debt (Recent Filing)$734.74M
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Oct 30, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,127,760
10 Day Avg. Volume311,747
30 Day Avg. Volume336,404
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue7.78
Enterprise Value/Gross Profit11.15
Enterprise Value/Ebitda-94.99
Forecast
1Y Price Target
$195.46Price Target Upside7.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
AI TechnologyThe company's unique AI differentiation is noted for having the highest accuracy in the industry.
Market LeadershipIRTC is a premium SMID cap growth company and a leader with approximately 70% market share in the long term continuous monitoring market.
Revenue Growth PotentialPlans to launch a multi-parameter sensor could drive higher revenue per sensor.
Bears Say
Irhythm Technologies News
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $67.92 and its highest was $188.53 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $5.95B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Oct 30, 2025 which is today.
How were Irhythm Technologies’s earnings last quarter?
Currently, no data Available
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -0.32.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 32,127,760 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Irhythm Technologies?
Currently, no hedge funds are holding shares in IRTC
Irhythm Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$195.46 (7.00% Upside)
$195.46 (7.00% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 301.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $669.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 15.3%
Last 30 Days ▲ 15.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
139.41%
12-Months-Change
Fundamentals
Return on Equity
-91.13%
Trailing 12-Months
Asset Growth
4.88%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies (IRTC) is a digital healthcare company that specializes in the development of innovative solutions for cardiac monitoring and arrhythmia detection. Operating primarily in the healthcare sector, iRhythm focuses on transforming the way cardiac arrhythmias are diagnosed and managed through its proprietary Zio service, which combines a wearable ECG monitoring device with advanced data analytics and interpretation capabilities. The company's core products include the Zio XT and Zio AT devices, designed to provide continuous cardiac monitoring for patients, enabling clinicians to obtain critical insights into heart health.
IRTC Company Deck
IRTC Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive sentiment, with significant revenue growth, strategic partnerships, and international expansion contributing to the optimism. While there are some challenges related to FDA remediation and potential tariff impacts, the overall outlook remains robust due to effective execution and innovative initiatives.View all IRTC earnings summariesIRTC Stock 12 Month Forecast
Average Price Target
$195.46
▲(7.00% Upside)
Technical Analysis
Ownership Overview
1.64% Insiders
36.81% Mutual Funds
0.34% Other Institutional Investors
45.58% Public Companies and
Individual Investors